{"id":"https://openalex.org/W4379283656","doi":"https://doi.org/10.1200/jco.2023.41.16_suppl.3027","title":"Mirzotamab clezutoclax as monotherapy and in combination with taxane therapy in relapsed/refractory solid tumors: Dose expansion results.","display_name":"Mirzotamab clezutoclax as monotherapy and in combination with taxane therapy in relapsed/refractory solid tumors: Dose expansion results.","publication_year":2023,"publication_date":"2023-06-01","ids":{"openalex":"https://openalex.org/W4379283656","doi":"https://doi.org/10.1200/jco.2023.41.16_suppl.3027"},"language":"en","primary_location":{"id":"doi:10.1200/jco.2023.41.16_suppl.3027","doi":"https://doi.org/10.1200/jco.2023.41.16_suppl.3027","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2023.41.16_suppl.3027","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5069923958","display_name":"Benedito A. Carneiro","orcid":"https://orcid.org/0000-0002-5468-1126","observed_orcids":["https://orcid.org/0000-0002-5468-1126"]},"institutions":[{"id":"https://openalex.org/I27804330","display_name":"Brown University","ror":"https://ror.org/05gq02987","country_code":"US","type":"education","lineage":["https://openalex.org/I27804330"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Benedito A. Carneiro","raw_affiliation_strings":["Legorreta Cancer Center, Brown University, Providence, RI"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Legorreta Cancer Center, Brown University, Providence, RI","institution_ids":["https://openalex.org/I27804330"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5035384872","display_name":"Ruth Perets","orcid":"https://orcid.org/0000-0001-7216-6577","observed_orcids":["https://orcid.org/0000-0001-7216-6577"]},"institutions":[{"id":"https://openalex.org/I2801301638","display_name":"Rambam Health Care Campus","ror":"https://ror.org/01fm87m50","country_code":"IL","type":"healthcare","lineage":["https://openalex.org/I2801301638"]}],"countries":["IL"],"is_corresponding":false,"raw_author_name":"Ruth Perets","raw_affiliation_strings":["Department of Oncology, Clinical Research Institute at Rambam, Rambam Medical Center, Haifa, Israel"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Oncology, Clinical Research Institute at Rambam, Rambam Medical Center, Haifa, Israel","institution_ids":["https://openalex.org/I2801301638"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5036587861","display_name":"Afshin Dowlati","orcid":"https://orcid.org/0000-0003-4535-6839","observed_orcids":["https://orcid.org/0000-0003-4535-6839"]},"institutions":[{"id":"https://openalex.org/I4210119077","display_name":"University Hospitals Seidman Cancer Center","ror":"https://ror.org/02kb97560","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799343972","https://openalex.org/I4210119077"]},{"id":"https://openalex.org/I58956616","display_name":"Case Western Reserve University","ror":"https://ror.org/051fd9666","country_code":"US","type":"education","lineage":["https://openalex.org/I58956616"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Afshin Dowlati","raw_affiliation_strings":["University Hospitals Seidman Cancer Center and Case Western Reserve University, Cleveland, OH"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University Hospitals Seidman Cancer Center and Case Western Reserve University, Cleveland, OH","institution_ids":["https://openalex.org/I4210119077","https://openalex.org/I58956616"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5064953304","display_name":"Patricia Mucci LoRusso","orcid":"https://orcid.org/0000-0001-7144-036X","observed_orcids":["https://orcid.org/0000-0001-7144-036X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Patricia LoRusso","raw_affiliation_strings":["University School of Medicine, New Haven, CT"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University School of Medicine, New Haven, CT","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5021522674","display_name":"Kan Yonemori","orcid":"https://orcid.org/0000-0002-7624-7611","observed_orcids":["https://orcid.org/0000-0002-7624-7611"]},"institutions":[{"id":"https://openalex.org/I4405285273","display_name":"National Cancer Center Hospital","ror":"https://ror.org/053hhpd64","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4210087348","https://openalex.org/I4405285273"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Kan Yonemori","raw_affiliation_strings":["Department of Breast and Medical Oncology, National Cancer Center Hospital, Tokyo, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Breast and Medical Oncology, National Cancer Center Hospital, Tokyo, Japan","institution_ids":["https://openalex.org/I4405285273"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5065903112","display_name":"Lei He","orcid":"https://orcid.org/0000-0001-6941-2466","observed_orcids":["https://orcid.org/0000-0001-6941-2466"]},"institutions":[{"id":"https://openalex.org/I2948539688","display_name":"AbbVie (United States)","ror":"https://ror.org/02g5p4n58","country_code":"US","type":"company","lineage":["https://openalex.org/I2948539688"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Lei He","raw_affiliation_strings":["AbbVie Inc., North Chicago, IL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"AbbVie Inc., North Chicago, IL","institution_ids":["https://openalex.org/I2948539688"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5081179675","display_name":"Wijith P. Munasinghe","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2948539688","display_name":"AbbVie (United States)","ror":"https://ror.org/02g5p4n58","country_code":"US","type":"company","lineage":["https://openalex.org/I2948539688"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Wijith Munasinghe","raw_affiliation_strings":["AbbVie Inc., North Chicago, IL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"AbbVie Inc., North Chicago, IL","institution_ids":["https://openalex.org/I2948539688"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5076197892","display_name":"Behnam Noorani","orcid":"https://orcid.org/0000-0002-5736-5989","observed_orcids":["https://orcid.org/0000-0002-5736-5989"]},"institutions":[{"id":"https://openalex.org/I2948539688","display_name":"AbbVie (United States)","ror":"https://ror.org/02g5p4n58","country_code":"US","type":"company","lineage":["https://openalex.org/I2948539688"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Behnam Noorani","raw_affiliation_strings":["AbbVie Inc., North Chicago, IL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"AbbVie Inc., North Chicago, IL","institution_ids":["https://openalex.org/I2948539688"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5090868883","display_name":"Eric Feral Johnson","orcid":"https://orcid.org/0000-0002-2909-865X","observed_orcids":["https://orcid.org/0000-0002-2909-865X"]},"institutions":[{"id":"https://openalex.org/I2948539688","display_name":"AbbVie (United States)","ror":"https://ror.org/02g5p4n58","country_code":"US","type":"company","lineage":["https://openalex.org/I2948539688"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Eric Feral Johnson","raw_affiliation_strings":["AbbVie Inc., North Chicago, IL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"AbbVie Inc., North Chicago, IL","institution_ids":["https://openalex.org/I2948539688"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5063439924","display_name":"Jon Zugazagoitia","orcid":"https://orcid.org/0000-0001-9352-5882","observed_orcids":["https://orcid.org/0000-0001-9352-5882"]},"institutions":[{"id":"https://openalex.org/I4210101691","display_name":"Hospital Universitario 12 De Octubre","ror":"https://ror.org/00qyh5r35","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210101691","https://openalex.org/I4210139293"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Jon Zugazagoitia","raw_affiliation_strings":["Department of Medical Oncology, 12 de Octubre University Hospital, Madrid, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Oncology, 12 de Octubre University Hospital, Madrid, Spain","institution_ids":["https://openalex.org/I4210101691"]}]}],"institutions":[],"countries_distinct_count":4,"institutions_distinct_count":7,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":20,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"41","issue":"16_suppl","first_page":"3027","last_page":"3027"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10294","display_name":"Cell death mechanisms and regulation","score":0.4259999990463257,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10294","display_name":"Cell death mechanisms and regulation","score":0.4259999990463257,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":0.11599999666213989,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.07999999821186066,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/antibody-drug-conjugates","display_name":"antibody-drug conjugates","score":0.9480000138282776},{"id":"https://openalex.org/keywords/bcl-xl-inhibition","display_name":"BCL-XL inhibition","score":0.9039999842643738},{"id":"https://openalex.org/keywords/b7-h3","display_name":"B7-H3","score":0.8569999933242798},{"id":"https://openalex.org/keywords/relapsed-refractory-solid-tumors","display_name":"relapsed/refractory solid tumors","score":0.8999999761581421},{"id":"https://openalex.org/keywords/small-cell-lung-cancer","display_name":"small cell lung cancer","score":0.8949999809265137},{"id":"https://openalex.org/keywords/non-small-cell-lung-cancer","display_name":"non-small cell lung cancer","score":0.9990000128746033},{"id":"https://openalex.org/keywords/docetaxel","display_name":"docetaxel","score":0.8360000252723694},{"id":"https://openalex.org/keywords/paclitaxel","display_name":"paclitaxel","score":1.0},{"id":"https://openalex.org/keywords/taxane-combination-therapy","display_name":"taxane combination therapy","score":0.8050000071525574},{"id":"https://openalex.org/keywords/monotherapy","display_name":"monotherapy","score":0.4830000102519989}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9120360612869263},{"id":"https://openalex.org/C2777511904","wikidata":"https://www.wikidata.org/wiki/Q425227","display_name":"Taxane","level":4,"score":0.7869670987129211},{"id":"https://openalex.org/C2781190966","wikidata":"https://www.wikidata.org/wiki/Q420436","display_name":"Docetaxel","level":3,"score":0.7042961716651917},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6792135834693909},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.618104875087738},{"id":"https://openalex.org/C142424586","wikidata":"https://www.wikidata.org/wiki/Q7307572","display_name":"Refractory (planetary science)","level":2,"score":0.5537002086639404},{"id":"https://openalex.org/C2777292972","wikidata":"https://www.wikidata.org/wiki/Q423762","display_name":"Paclitaxel","level":3,"score":0.47892531752586365},{"id":"https://openalex.org/C2776256026","wikidata":"https://www.wikidata.org/wiki/Q47912","display_name":"Lung cancer","level":2,"score":0.4522255063056946},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.40052151679992676},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.37552642822265625},{"id":"https://openalex.org/C87355193","wikidata":"https://www.wikidata.org/wiki/Q411","display_name":"Astrobiology","level":1,"score":0.0},{"id":"https://openalex.org/C121332964","wikidata":"https://www.wikidata.org/wiki/Q413","display_name":"Physics","level":0,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1200/jco.2023.41.16_suppl.3027","doi":"https://doi.org/10.1200/jco.2023.41.16_suppl.3027","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2023.41.16_suppl.3027","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"sustainable_development_goals_aurora":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.8399999737739563}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W1996698721","https://openalex.org/W1982849070","https://openalex.org/W1753522318","https://openalex.org/W181195935","https://openalex.org/W2411149337","https://openalex.org/W2388526109","https://openalex.org/W2078530790","https://openalex.org/W2415527985","https://openalex.org/W2095756161","https://openalex.org/W2051573328"],"abstract_inverted_index":{"3027":[0],"Background:":[1],"Mirzotamab":[2],"clezutoclax":[3],"(ABBV-155;":[4],"Mirzo-C)":[5],"is":[6,402],"a":[7,18,22,44,264,348],"first-in-class":[8],"antibody-drug":[9],"conjugate":[10],"with":[11,32,43,94,103,118,295,355,363,378,411],"three":[12],"components:":[13],"an":[14,64],"anti\u2013B7-H3":[15],"monoclonal":[16],"antibody,":[17],"solubilizing":[19],"linker,":[20],"and":[21,107,139,176,199,219,237,258,305,322,341,354,384,392],"BCL-XL":[23,271],"inhibitor":[24,114],"payload.":[25],"By":[26],"specific":[27],"targeting":[28],"of":[29,63,77,146,184,187,210,266,270,368],"BCL-XL,":[30],"synergy":[31],"other":[33],"anticancer":[34],"agents":[35],"was":[36,49,123,164,190,206,245,273,284,293,332,361,370,399],"observed":[37,275,286,362,371],"in":[38,51,192,197,201,212,217,221,229,250,259,276,287,317,324,334,339,343,372,388],"preclinical":[39],"models.":[40],"When":[41],"combined":[42],"taxane,":[45],"clinical":[46],"antitumor":[47],"activity":[48,367],"reported":[50],"relapsed":[52],"and/or":[53],"refractory":[54],"(R/R)":[55],"solid":[56],"tumors":[57],"during":[58],"the":[59,73,78,126,169,193,213,246,267,277,288,318,335,407],"dose":[60,74,130,133],"escalation":[61],"phase":[62,76],"ongoing":[65],"Phase":[66,79,128],"1,":[67],"open-label":[68],"study":[69],"(NCT03595059).":[70],"Methods:":[71],"In":[72],"expansion":[75],"1":[80,323],"study,":[81],"patients":[82,151,211,316],"were":[83,137,152,231,376],"treated":[84],"as":[85,352],"follows:":[86],"(i)":[87],"R/R":[88],"small":[89],"cell":[90,99],"lung":[91,100],"cancer":[92,101,116],"(SCLC)":[93],"Mirzo-C":[95,104,119,122,278,346,369,405],"monotherapy,":[96],"(ii)":[97],"non-small":[98],"(NSCLC)":[102],"+":[105,120],"docetaxel,":[106],"(iii)":[108],"hormone":[109],"positive,":[110],"Her2":[111],"negative,":[112],"post\u2013CDK4/6":[113],"breast":[115],"(BrCa)":[117],"paclitaxel.":[121],"administered":[124],"at":[125,132],"recommended":[127],"2":[129,191,196],"determined":[131],"escalation.":[134],"Primary":[135],"objectives":[136],"safety":[138,350],"overall":[140,381],"response":[141,382],"rate":[142],"(ORR).":[143],"Results:":[144],"As":[145],"November":[147],"18,":[148],"2022,":[149],"78":[150],"enrolled":[153],"(SCLC":[154],"n=14;":[155],"NSCLC":[156,251,306,319,391],"n=36;":[157],"BrCa":[158,260,296,325,393],"n=28).":[159],"The":[160,181,223],"median":[161,182],"(range)":[162],"follow-up":[163],"2.0":[165],"(0.6\u20139.1)":[166],"months":[167],"for":[168,174,179,241],"SCLC":[170,194,214,230,289,336],"cohort,":[171,195,215,337],"4.9":[172],"(0.6\u20138.5)":[173],"NSCLC,":[175,198,218,340],"10.4":[177],"(0.8\u201313.3)":[178],"BrCa.":[180,202,222,344],"number":[183],"prior":[185],"lines":[186],"systemic":[188,268],"therapy":[189,205],"6":[200],"Prior":[203],"taxane":[204],"received":[207],"by":[208],"7%":[209],"36%":[216],"64%":[220],"most":[224,247],"common":[225,248,294],"adverse":[226],"events":[227],"(AEs)":[228],"fatigue,":[232],"increased":[233],"aspartate":[234],"aminotransferase,":[235],"diarrhea,":[236],"headache":[238],"(21%,":[239],"n=3":[240],"each":[242],"AE);":[243],"fatigue":[244],"AE":[249],"(58%,":[252],"n=21;":[253],"Grade":[254,301,311,396],"3/4:":[255,302,312],"3%,":[256],"n=1)":[257],"(61%,":[261],"n=17).":[262],"Thrombocytopenia,":[263],"result":[265],"effects":[269],"inhibitors,":[272],"not":[274,285],"monotherapy":[279,290,353],"cohort.":[280],"Neutropenia/decreased":[281],"neutrophil":[282],"count":[283],"cohort":[291,320],"but":[292],"paclitaxel":[297],"combo":[298,308],"(64%,":[299],"n=18;":[300],"29%,":[303],"n=8)":[304],"docetaxel":[307],"(53%,":[309],"n=19;":[310],"44%,":[313],"n=16);":[314],"5":[315],"(14%)":[321],"(4%)":[326],"had":[327],"febrile":[328],"neutropenia.":[329],"Confirmed":[330],"ORR":[331],"0%":[333],"11%":[338],"18%":[342],"Conclusions:":[345],"demonstrated":[347],"tolerable":[349],"profile":[351],"taxanes.":[356,412],"No":[357,365],"thrombocytopenia":[358],"or":[359],"neutropenia":[360,398,408],"monotherapy.":[364],"single-agent":[366],"SCLC.":[373],"Combination":[374],"treatments":[375],"active":[377],"high":[379],"best":[380],"(BOR)":[383],"disease":[385],"control":[386],"rates":[387],"heavily":[389],"pretreated":[390],"patients,":[394],"where":[395],"3/4":[397],"observed.":[400],"It":[401],"unknown":[403],"if":[404],"exacerbated":[406],"risk":[409],"associated":[410],"Clinical":[413],"trial":[414],"information:":[415],"NCT03595059":[416],".":[417],"[Table:":[418],"see":[419],"text]":[420]},"counts_by_year":[{"year":2026,"cited_by_count":4},{"year":2025,"cited_by_count":13},{"year":2024,"cited_by_count":3}],"updated_date":"2026-10-14T16:39:01.820549","created_date":"2025-10-10T00:00:00"}